Does Foundayo increase heart rate?
Note: The first passage is from the Prescribing Information (pool of Trials 1 and 2). The second is the pulse rate row of Table 7 of the Prescribing Information; its columns are Trial 1 (without diabetes) placebo, FOUNDAYO 5.5 mg, 9 mg, and 17.2 mg, then Trial 2 (with type 2 diabetes) placebo, FOUNDAYO 5.5 mg, 9 mg, and 17.2 mg, as in the table header. In each "difference from placebo" row the placebo cells are empty. Footnote d marks results not controlled for multiplicity. The Prescribing Information is the governing source: Table 7 gives Trial 1 (ATTAIN-1) mean pulse rate changes of 3.6, 3.9, and 4.6 beats per minute for Foundayo 5.5 mg, 9 mg, and 17.2 mg against 0.6 with placebo. The third passage, from the cardiometabolic section of the clinical data page of the Foundayo HCP site, gives ATTAIN-1 increases of 4.3 to 5.3 beats per minute against 0.8 with placebo, citing the ATTAIN-1 publication; the two sources differ on these figures. The Prescribing Information presents these safety data from trials of an investigational orforglipron formulation, shown as equivalent dosages of once-daily Foundayo.